Escitalopram
Mood Disorder
First Affiliated Hospital of Zhejiang UniversitySmall moleculePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
10 Active assets in the Mood Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Quetiapine First Affiliated Hospital of Zhejiang University | Phase 4 | BBB |
Brexpiprazole Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 | BBB |
Fluoxetine University of Ghana Medical School | Phase 4 | BBB |
Olanzapine University of Ghana Medical School | Phase 4 | BBB |
Minocycline Pakistan Institute of Living and Learning | Phase 4 | BBB |
View all 33 →
Same molecule, other indications
Escitalopram is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →